Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts von Chu, Yaya, Nayyar, Gaurav, Tian, Meijuan, Lee, Dean A, Ozkaynak, Mehmet F, Ayala-Cuesta, Jessica, Klose, Kayleigh, Foley, Keira, Mendelowitz, Alyssa S, Luo, Wen, Liao, Yanling, Ayello, Janet, Behbehani, Gregory K, Riddell, Stanley, Cripe, Tim, Cairo, Mitchell S

Volltext

Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL) von Chu, Yaya, Foley, Keira, Tian, Meijuan, Klose, Kayleigh, Ayala-Cuesta, Jessica, Lee, Dean Anthony, Marcondes, Mario, Klein, Christian, Cairo, Mitchell S.

Volltext

Combinatorial immunotherapy with anti-ROR1 CAR engineered ex-vivo expanded NK cells and an IL-21 secreting oncolytic virus against neuroblastoma von Chu, Yaya, Tian, Meijuan, Saini, Uksha, Ayala-Cuesta, Jessica, Klose, Kayleigh, Mendelowitz, Alyssa S., Foley, Keira, Ozkaynak, Mehmet F., Luo, Wen, Cripe, Timothy P., Lee, Dean A., Cassady, Kevin A., Cairo, Mitchell S.

Volltext

IL15 (N-803) and IL21 (oHSV-21) Significantly Enhance ROR1 CAR NK Cells Against Pediatric Neuroblastoma von Chu, Yaya, Tian, Meijuan, Saini, Uksha, Ayala-Cuesta, Jessica, Klose, Kayleigh, Foley, Keira, Mendelowitz, Alyssa S., Cripe, Timothy P, Lee, Dean Anthony, Riddell, Stanley R., Cassady, Kevin A., Cairo, Mitchell S.

Volltext